These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 14612136)

  • 21. Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.
    Choi SW; Elmaleh DR; Hanson RN; Fischman AJ
    J Med Chem; 1999 Sep; 42(18):3647-56. PubMed ID: 10479296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-activity relationships at the monoamine transporters and sigma receptors for a novel series of 9-[3-(cis-3, 5-dimethyl-1-piperazinyl)propyl]carbazole (rimcazole) analogues.
    Husbands SM; Izenwasser S; Kopajtic T; Bowen WD; Vilner BJ; Katz JL; Newman AH
    J Med Chem; 1999 Oct; 42(21):4446-55. PubMed ID: 10543888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of monoamine transporters by common biogenic amines via trace amine-associated receptor 1 and monoamine autoreceptors in human embryonic kidney 293 cells and brain synaptosomes.
    Xie Z; Westmoreland SV; Miller GM
    J Pharmacol Exp Ther; 2008 May; 325(2):629-40. PubMed ID: 18310473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in sodium-ion coupled biogenic amine transporters.
    Graham D; Langer SZ
    Life Sci; 1992; 51(9):631-45. PubMed ID: 1501510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel fluorescence-based approaches for the study of biogenic amine transporter localization, activity, and regulation.
    Mason JN; Farmer H; Tomlinson ID; Schwartz JW; Savchenko V; DeFelice LJ; Rosenthal SJ; Blakely RD
    J Neurosci Methods; 2005 Apr; 143(1):3-25. PubMed ID: 15763132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and pharmacological evaluation of 3-(3,4-dichlorophenyl)-1-indanamine derivatives as nonselective ligands for biogenic amine transporters.
    Yu H; Kim IJ; Folk JE; Tian X; Rothman RB; Baumann MH; Dersch CM; Flippen-Anderson JL; Parrish D; Jacobson AE; Rice KC
    J Med Chem; 2004 May; 47(10):2624-34. PubMed ID: 15115403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies of the biogenic amine transporters. VII. Characterization of a novel cocaine binding site identified with [125I]RTI-55 in membranes prepared from human, monkey and guinea pig caudate.
    Rothman RB; Silverthorn ML; Glowa JR; Matecka D; Rice KC; Carroll FI; Partilla JS; Uhl GR; Vandenbergh DJ; Dersch CM
    Synapse; 1998 Apr; 28(4):322-38. PubMed ID: 9517841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and dopamine transporter binding affinities of 3alpha-benzyl-8-(diarylmethoxyethyl)-8-azabicyclo[3.2.1]octanes.
    Bradley AL; Izenwasser S; Wade D; Klein-Stevens C; Zhu N; Trudell ML
    Bioorg Med Chem Lett; 2002 Sep; 12(17):2387-90. PubMed ID: 12161139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopamine transporter binding without cocaine-like behavioral effects: synthesis and evaluation of benztropine analogs alone and in combination with cocaine in rodents.
    Katz JL; Agoston GE; Alling KL; Kline RH; Forster MJ; Woolverton WL; Kopajtic TA; Newman AH
    Psychopharmacology (Berl); 2001 Apr; 154(4):362-74. PubMed ID: 11349389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.
    Froimowitz M; Wu KM; Moussa A; Haidar RM; Jurayj J; George C; Gardner EL
    J Med Chem; 2000 Dec; 43(26):4981-92. PubMed ID: 11150168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Piperidine-based nocaine/modafinil hybrid ligands as highly potent monoamine transporter inhibitors: efficient drug discovery by rational lead hybridization.
    Zhou J; He R; Johnson KM; Ye Y; Kozikowski AP
    J Med Chem; 2004 Nov; 47(24):5821-4. PubMed ID: 15537337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid regulation of dopamine transporter function by substrates, blockers and presynaptic receptor ligands.
    Gulley JM; Zahniser NR
    Eur J Pharmacol; 2003 Oct; 479(1-3):139-52. PubMed ID: 14612145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-activity relationship studies of 4-[2-(diphenylmethoxy)ethyl]-1-benzylpiperidine derivatives and their N-analogues: evaluation of O-and N-analogues and their binding to monoamine transporters.
    Dutta AK; Fei XS; Beardsley PM; Newman JL; Reith ME
    J Med Chem; 2001 Mar; 44(6):937-48. PubMed ID: 11300876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta-phenylethylamine alters monoamine transporter function via trace amine-associated receptor 1: implication for modulatory roles of trace amines in brain.
    Xie Z; Miller GM
    J Pharmacol Exp Ther; 2008 May; 325(2):617-28. PubMed ID: 18182557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective actions as norepinephrine transporter substrates.
    Rothman RB; Vu N; Partilla JS; Roth BL; Hufeisen SJ; Compton-Toth BA; Birkes J; Young R; Glennon RA
    J Pharmacol Exp Ther; 2003 Oct; 307(1):138-45. PubMed ID: 12954796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of dopamine uptake inhibition on brain catecholamine levels and locomotion in catechol-O-methyltransferase-disrupted mice.
    Huotari M; Santha M; Lucas LR; Karayiorgou M; Gogos JA; Männistö PT
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1309-16. PubMed ID: 12438556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of dopamine transporter function and plasma membrane expression by dopamine, amphetamine, and cocaine.
    Kahlig KM; Galli A
    Eur J Pharmacol; 2003 Oct; 479(1-3):153-8. PubMed ID: 14612146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the subregional distributions of the monoamine vesicular transporter and dopamine uptake complex in the rat striatum and changes during aging.
    Leroux-Nicollet I; Costentin J
    J Neural Transm Gen Sect; 1994; 97(2):93-106. PubMed ID: 7873127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of substituted 3,4-diphenyl-thiazoles as a novel class of monoamine transporter inhibitors through 3-D pharmacophore search using a new pharmacophore model derived from mazindol.
    Enyedy IJ; Wang J; Zaman WA; Johnson KM; Wang S
    Bioorg Med Chem Lett; 2002 Jul; 12(13):1775-8. PubMed ID: 12067559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of dopamine transporter selective 3-[2-(diarylmethoxyethylidene)]-8-alkylaryl-8-azabicyclo[3.2.1]octanes.
    Bradley AL; Izenwasser S; Wade D; Cararas S; Trudell ML
    Bioorg Med Chem Lett; 2003 Feb; 13(4):629-32. PubMed ID: 12639545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.